"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "

NCT02530424 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Palbociclib
DRUG: Fulvestrant

Sponsor

Fondazione Michelangelo